Generics

Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA.

EquiCoxib is a non-steroidal anti-inflammatory drug used for pain and inflammation associated with osteoarthritis.

AAM said the law sets up a process under which a drug would have price controls applied before a generic or biosimilar even had the chance to come to market.

Impax Laboratories and Dr. Reddy’s have settled their patent infringement dispute over Rytary, a medication used to treat Parkinson’s disease.

A Tebra survey found that 84% of Americans believe generic medications are just as effective as their brand-name counterparts.

Natco is the first-to-file for this product and is eligible for 180 days exclusivity.

Axsome will grant Teva a license to sell its generic version of Auvelity beginning on or after March 31, 2039, if pediatric exclusivity is granted, or on or after Sept. 30, 2038, if no pediatric exclusivity is granted.

Diltiazem HcL ER capsules are indicated for the treatment of hypertension.